The preservation of the intestinal mucosal barrier in the EIN + L-OHP group, as indicated by higher levels of ZO-1 and Occludin, also suggests that EIN may help protect against chemotherapy-induced gut toxicity, a major complication that can limit treatment intensity in cancer patients [26, 27]. The gene discussed is TJP1; the disease is cancer.